Pharmabcine Inc.

Sungho Ahn

Jin-San Yoo

Weon Sup Lee

Sang Soon Byun

Eun Hee Lee

Miju Park

Keunhee Oh

Do-Yun Kim

Jinsang Yoo

Youngae Lee

Do-yun Kim

Hyuk Joon Lee

Jung Min Ha

Shin Ae Yi

Disclosed are an anti-PD-L1 antibody or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, a pharmaceutical composition for preventing or treating cancer containing the same, and a composition for co-administration with an antibody other than an antibody binding to PD-L1, containing the same.

Anti-PD-L1 antibody and use thereof

The present invention relates to an anti-VISTA antibody or an antigen binding fragment thereof, a nucleic acid coding for the same, a vector carrying the nucleic acid, a cell transformed with the vector, a method for preparing the antibody or an antigen binding fragment thereof, a composition for prevention or treatment of autoimmune disease, comprising the same antibody, and a composition for concurrent administration in combination with a PD-1 antibody or PD-L1 antibody.

Anti-VISTA antibody and use thereof

Growing community of inventors

Chungcheongbuk-do, South Korea

Sungho Ahn